Independent compliance review service. Not affiliated with, or endorsed by, the Therapeutic Goods Administration.

Compliance guide

Ahpra Advertising Rules for Cannabis Prescribers and Clinics

Updated 4 July 2026 · 6 min read · Section 42 Compliance

Quick answer — Do Ahpra rules apply on top of TGA rules?

Yes — two regulators police the same marketing. The TGA enforces the Therapeutic Goods Act against anyone advertising; Ahpra and the National Boards regulate registered practitioners and can also pursue businesses that direct or incite practitioner misconduct, with fines up to $120,000 under the National Law. Since 2019 Ahpra has taken action against 80 practitioners over cannabis prescribing or dispensing, and it now proactively monitors prescribing data with the TGA to identify outliers without a complaint being filed.

The practitioner layer

Registered practitioners face the National Law's advertising requirements — no testimonials, no false or misleading claims, no unreasonable expectation of benefit — plus Ahpra's cannabis-specific prescriber guidance. That guidance calls out real patterns from the enforcement record: consultations lasting seconds or minutes, prescribing because the patient requested a product, and conflicts of interest where practitioners prescribe only products supplied by an associated company.

Ahpra's Rapid Regulatory Response Oversight Group meets quarterly to identify emerging risks, monitors prescribing patterns in high-demand areas like telehealth cannabis, and acts on outliers — including practitioners identified purely from data, such as prescribers issuing more than 10,000 scripts in six months.

The business layer most operators miss

Clinic operators who are not practitioners still carry two exposures. First, TGA advertising liability for the business's own marketing. Second, National Law liability for directing or inciting practitioners to breach their obligations — for example, marketing that promises outcomes practitioners must then deliver on, KPI structures that compress consultations, or scripting that steers prescribing. Vertically integrated models are under particular scrutiny from both regulators and professional bodies.

For marketing specifically: practitioner bios, 'meet the doctor' pages and practitioner-fronted content sit at the junction of both regimes, and are audited under both rule sets in our engine.

Frequently asked questions

Can a practitioner appear in our marketing at all?

Yes, within limits — credentials and role are fine; endorsement of cannabis, outcome claims, or condition references through the practitioner's voice are not.

What is the fine for a business inciting practitioner misconduct?

Up to $120,000 per offence under section 136 of the National Law, separate from any TGA penalties.

Does Ahpra need a complaint to act?

No. Ahpra proactively monitors prescribing and dispensing patterns and shares data with the TGA to identify outliers.

We're a pharmacy, not a clinic — does this apply?

Yes. Pharmacists are registered practitioners, dispensing patterns are monitored, and pharmacy marketing faces both regimes.

Check where you stand

The breach patterns in this guide are exactly what our audit engine checks. Start with the free 10-point self-assessment, a $149 rapid scan, or the $449 full audit. Everything is delivered by email.